F Fuh
Overview
Explore the profile of F Fuh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefanich E, Danilenko D, Wang H, OByrne S, Erickson R, Gelzleichter T, et al.
Br J Pharmacol
. 2011 Jan;
162(8):1855-70.
PMID: 21232034
Background And Purpose: rhuMAb Beta7 is a humanized anti-human β7 monoclonal antibody currently in phase I in inflammatory bowel disease. rhuMAb Beta7 binds the β7 subunit of the integrins α4β7...
2.
Polson A, Williams M, Gray A, Fuji R, Poon K, McBride J, et al.
Leukemia
. 2010 Jul;
24(9):1566-73.
PMID: 20596033
Antibody-drug conjugates (ADCs) are potent cytotoxic drugs linked to antibodies through chemical linkers, and allow specific targeting of drugs to neoplastic cells. The expression of CD22 is limited to B-cells,...
3.
Subauste C, Fuh F, de Waal Malefyt R, Remington J
J Immunol
. 1998 Apr;
160(7):3403-11.
PMID: 9531300
The mechanisms by which T cells from previously unexposed hosts respond in vitro to certain intracellular pathogens remain to be fully understood. We report and characterize the in vitro reactivity...
4.
Subauste C, de Waal Malefyt R, Fuh F
J Immunol
. 1998 Feb;
160(4):1831-40.
PMID: 9469444
The costimulatory ligands CD80 and CD86 play a crucial role in the initiation and maintenance of an immune response. We demonstrate that whereas infection of human monocytes with viable tachyzoites...